Evidence map›Paper›PMID 40867894›Full record

ReviewAntioxidants (Basel, Switzerland)2025

Cyclodextrin-Based Delivery Systems for Flavonoids: Mechanisms, Advances, Formulation, and Application Opportunities.

Ferenc Fenyvesi, Ágnes Klusóczki, Ágnes Rusznyák, Barbara Zsebik, Ildikó Bácskay, Judit Váradi

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ferenc FenyvesiDepartment of Molecular and Nanopharmaceutics, Faculty of Pharmacy, University of Debrecen, H-4002 Debrecen, Hungary.ORCID 0000-0003-2890-0783
Ágnes KlusóczkiDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, H-4002 Debrecen, Hungary.
Ágnes RusznyákDepartment of Molecular and Nanopharmaceutics, Faculty of Pharmacy, University of Debrecen, H-4002 Debrecen, Hungary.ORCID 0000-0002-8837-7499
Barbara ZsebikDepartment of Biopharmacy, Faculty of Pharmacy, University of Debrecen, H-4002 Debrecen, Hungary.ORCID 0009-0007-0326-1424
Ildikó BácskayDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, H-4002 Debrecen, Hungary.ORCID 0000-0001-8663-2890
Judit VáradiDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, H-4002 Debrecen, Hungary.ORCID 0000-0003-1885-164X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavonoids play an important role in preventive and therapeutic research due to their significant antioxidant properties. However, their application is limited by several pharmacokinetic drawbacks, such as poor water solubility and low bioavailability. Cyclodextrin-based delivery systems offer an opportunity to overcome these disadvantages. Cyclodextrins are able to form stable, water-soluble inclusion complexes with flavonoids, thereby improving their solubility, chemical stability, and antioxidant activity. This review summarizes the structural characteristics and complexation mechanisms of various flavonoid-cyclodextrin complexes and examines how these interactions influence biological activity. Special attention is given to nanotechnological formulations-such as liposomes, nanofibers, and nanosponges-that enable targeted drug delivery and enhanced therapeutic efficacy. The aim of this review is to provide a comprehensive overview of the role of cyclodextrin-based carriers in the formulation of flavonoids and to highlight the future potential of these systems in modern therapeutics and functional product development.

Indexed as

antioxidantcyclodextrinflavonoid–cyclodextrin complexesflavonoids

Identifiers

PMID40867894
PMCPMC12382938

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.